- Release Date: 09/09/13 17:44
- Summary: RELINT: FPH: Disclosure of Director and Officers Relevant Interests
- Price Sensitive: No
- Download Document 9.42KB
FPH 09/09/2013 15:44 RELINT REL: 1544 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Director and Officers Relevant Interests Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 46,667 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid for acqusition Not applicable If the relevant interest was disposed of-- Date of lapse 3 September 2013 Consideration received from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Lapse of options to acquire ordinary shares on expiry date of the 2008 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 5 September 2013 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 93,333 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid for acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 3 September 2013 Consideration received from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Lapse of options to acquire ordinary shares on expiry date of the 2008 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 5 September 2013 Name of director or officer of public issuer: Michael Robert BATTY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Former Group Operations Manager B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 32,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial interest Name of registered holder of securities Michael Robert BATTY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not Applicable Consideration paid for acquisition Not Applicable If the relevant interest was disposed of-- Date of lapse 3 September 2013 Consideration received from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Lapse of options to acquire ordinary shares on expiry date of the 2008 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 20 August 2013 Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 93,333 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid for acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 3 September 2013 Consideration received from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Lapse of options to acquire ordinary shares on expiry date of the 2008 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 5 September 2013 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: 66,667 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: Not applicable Consideration paid for acquisition: Not applicable If the relevant interest was disposed of-- Date of lapse: 3 September 2013 Consideration received from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Lapse of options to acquire ordinary shares on expiry date of the 2008 issue under the 2003 option plan. E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 5 September 2013 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 30,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition Not applicable Consideration paid for acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 3 September 2013 Consideration received from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Lapse of options to acquire ordinary shares on expiry date of the 2008 issue under the 2003 option plan. E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 5 September 2013 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 106,667 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Michael Grenfell DANIELL D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition Not applicable Consideration paid for acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 3 September 2013 Consideration received from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place Lapse of options to acquire ordinary shares on the expiry date of the 2008 issue under the 2003 option plan. E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 5 September 2013 End CA:00240895 For:FPH Type:RELINT Time:2013-09-09 15:44:17
Ann: RELINT: FPH: Disclosure of Director and Offi
Add to My Watchlist
What is My Watchlist?
